The Vanguard Group, Inc. (IRSH)

Form 8.3 – The Vanguard Group, Inc.: Mural Oncology plc 03-Jul-2025 / 15:44 GMT/BST

You might also be interested in reading Y-mAbs Therapeutics beats top-line and bottom-line estimates; initiates Q2 and reaffirms FY outlook.